![]() |
市场调查报告书
商品编码
1871084
重组蛋白食品配料市场机会、成长驱动因素、产业趋势分析及预测(2025-2034年)Recombinant Protein Food Ingredients Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球重组蛋白食品配料市场价值为 9 亿美元,预计到 2034 年将以 7.8% 的复合年增长率增长至 19 亿美元。

随着生物技术的进步和消费者对永续和功能性食品日益增长的需求重塑食品创新格局,该行业正迅速扩张。慢性病发病率的上升和对个人化营养的日益重视是推动市场需求的关键因素。製造商正在提升合成生物学、菌株工程和精准发酵的能力,以开发能够复製动物源蛋白的质地、营养成分和感官特性的蛋白质。这项进展使得大规模生产成为可能,重组蛋白从实验室概念转变为乳製品、肉类和饮料等应用领域的商业配料。永续性已成为这一发展进程的核心,生产商正致力于循环和低碳生产过程。诸如气体发酵和农业副产品利用等新技术正在降低碳排放强度,并有可能实现碳负排放蛋白的生产。这些永续发展措施符合全球脱碳和ESG目标,吸引了优先考虑环境责任的投资者。对环保生产方式的日益重视也增强了消费者的信任,并有助于获得全球监管机构的批准。
| 市场范围 | |
|---|---|
| 起始年份 | 2024 |
| 预测年份 | 2025-2034 |
| 起始值 | 9亿美元 |
| 预测值 | 19亿美元 |
| 复合年增长率 | 7.8% |
预计到2024年,精准发酵技术将占70%的市场。此技术利用基因工程改造的微生物生产高纯度、高稳定性的蛋白质,这些蛋白质与动物性蛋白质高度相似。由于其可扩展性、合规性和成本效益,精准发酵已成为行业标准,并支持乳製品、鸡蛋和肉类替代品的大规模生产。
2024年,结构蛋白市占率占40%,预计到2034年将达到7.78亿美元。这些蛋白质在食品配方中发挥着至关重要的作用,尤其是在植物肉、起司和烘焙食品等领域,它们赋予食物结构、稳定性和结合力。产业合作加速了生产进程,使得各种替代食品领域所需的关键蛋白质成分能够大规模生产。
2024年北美重组蛋白食品配料市场规模为3.79亿美元,预计2034年将以8%的复合年增长率成长。该地区受益于强大的生物技术生态系统、美国食品药物管理局(FDA)在GRAS框架下提供的有利监管路径、不断增长的风险投资以及消费者对可持续蛋白替代品日益增强的认知。此外,合作计画和资助计画也持续推动北美地区重组蛋白配料的生产和商业化。
全球重组蛋白食品配料市场的主要参与者包括帝斯曼-菲美意(DSM-Firmenich)、Geltor Inc.、Perfect Day Inc.、EVERY Company、Kerry Group plc、奇华顿(Givaudan SA)、Motif FoodWorks Inc.、诺维信(Novozymes A/S)、科汉森控股(Ihr)、A.a. Hansen(Novozymes A/S)、科汉森控股(I.3.H Foods)。这些公司正采取策略措施扩大市场占有率并提升竞争力。各公司大力投资研发,以优化蛋白质设计、提高生产效率,并透过精准发酵实现更好的规模化生产。与食品製造商和生技公司进行策略合作、建立伙伴关係和成立合资企业,有助于加速新型蛋白质的商业化进程。此外,各公司也正在扩大全球生产能力,并进军新的区域市场,以满足不断增长的需求。
The Global Recombinant Protein Food Ingredients Market was valued at USD 900 million in 2024 and is estimated to grow at a CAGR of 7.8% to reach USD 1.9 Billion by 2034.

The industry is expanding rapidly as advancements in biotechnology and the growing consumer preference for sustainable and functional foods reshape the food innovation landscape. Rising incidences of chronic illnesses and the growing emphasis on personalized nutrition are key drivers fueling market demand. Manufacturers are enhancing the capabilities of synthetic biology, strain engineering, and precision fermentation to develop proteins that replicate the texture, nutritional profile, and sensory characteristics of animal-derived proteins. This progress is enabling large-scale production, transforming recombinant proteins from laboratory concepts to commercial ingredients in dairy, meat, and beverage applications. Sustainability has become central to this evolution, with producers focusing on circular and low-carbon manufacturing processes. Novel technologies such as gas fermentation and the use of agricultural byproducts are reducing carbon intensity, potentially leading to carbon-negative protein production. These sustainable developments align with global decarbonization and ESG goals, attracting investors who prioritize environmental responsibility. The growing emphasis on eco-friendly production methods also strengthens consumer trust and global regulatory approval.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $900 Million |
| Forecast Value | $1.9 Billion |
| CAGR | 7.8% |
The precision fermentation segment held a 70% share in 2024, as this method utilizes engineered microorganisms to produce highly pure and consistent proteins that closely resemble animal proteins. This approach has become the industry standard due to its scalability, regulatory compliance, and cost-efficiency, supporting mass production for dairy, egg, and meat substitute applications.
The structural proteins segment held a 40% share in 2024 and is projected to reach USD 778 million by 2034. These proteins play a crucial role in providing structure, stability, and binding properties in food formulations, particularly within plant-based meat, cheese, and bakery applications. Industrial partnerships have accelerated the production process, enabling large-scale manufacturing of key protein ingredients used across alternative food segments.
North America Recombinant Protein Food Ingredients Market was valued at USD 379 million in 2024 and is expected to grow at a CAGR of 8% through 2034. The region benefits from a robust biotechnology ecosystem, favorable FDA regulatory pathways under the GRAS framework, increasing venture capital investments, and rising consumer awareness of sustainable protein alternatives. Additionally, collaborative initiatives and funding programs continue to strengthen the production and commercialization of recombinant protein ingredients across North America.
Leading companies in the Global Recombinant Protein Food Ingredients Market include DSM-Firmenich, Geltor Inc., Perfect Day Inc., The EVERY Company, Kerry Group plc, Givaudan SA, Motif FoodWorks Inc., Novozymes A/S, Chr. Hansen Holding A/S and Impossible Foods Inc. are Major players in the Recombinant Protein Food Ingredients Market and are employing strategic measures to expand their market presence and enhance competitiveness. Companies are heavily investing in research and development to optimize protein design, improve production efficiency, and achieve better scalability through precision fermentation. Strategic collaborations, partnerships, and joint ventures with food manufacturers and biotechnology firms are helping accelerate the commercialization of novel proteins. Firms are also expanding their global manufacturing capacities and entering new regional markets to meet rising demand.